← FDA DRUG APPROVALS
FDA ANDA · ANDA217409
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium and tazobactam sodium
Sponsor: EUGIA PHARMA
APPLICATION
ANDA217409
TYPE
ANDA
ORIGINAL APPROVAL
2023-10-12
LATEST ACTION
2024-12-03
ROUTE
INTRAVENOUS, POWDER,FOR SOLUTION, INJECTION
DOSAGE FORM
INJECTION, INJECTABLE
MARKETING STATUS
Prescription, Discontinued
Products
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM 0.375G · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMDiscontinued
PIPERACILLIN SODIUM EQ 36GM BASE/VIAL, TAZOBACTAM SODIUM EQ 4.5GM BASE/VIAL · INJECTABLE · INJECTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM 36G · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM 4.0G · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM 3.0G · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM EQ 36GM BASE/VIAL · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMDiscontinued
PIPERACILLIN SODIUM EQ 12GM BASE/VIAL, TAZOBACTAM SODIUM EQ 1.5GM BASE/VIAL · INJECTABLE · INJECTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM EQ 12GM BASE/VIAL · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM 4.5G · INJECTION · POWDER,FOR SOLUTION
PIPERACILLIN AND TAZOBACTAMPrescription
PIPERACILLIN,TAZOBACTAM 0.5G/1VIAL · INJECTION · POWDER,FOR SOLUTION
Approval history
2024-12-03Labeling · Supplement 5 · standardAP
2024-05-01Labeling · Supplement 1 · standardAP
2023-10-12UNKNOWN · Supplement 2 · standardAP
2023-10-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.